Use of 17-alpha Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor During Current Pregnancy. Double Blind, Randomized, Controlled Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preterm birth; Preterm labour
- Focus Therapeutic Use
Most Recent Events
- 06 Jan 2015 Biomarkers information updated
- 01 Jul 2013 Planned End Date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 27 Jul 2012 Planned End Date changed from 1 Aug 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.